Posts tagged All News
Bullish Momentum: 4 stocks with White Marubozu Pattern on Nov 1 (04-11-2024)
Represented by a long white (or green) candlestick with no upper shadow and a small or nonexistent lower shadow, it indicates strong buying pressure throughout the session
Donald Trump vs Kamala Harris: What US elections mean for Indian stock market (04-11-2024)
As the US presidential election remains too close to call, markets appear to be anticipating a Donald Trump victory and a Republican sweep on November 5. Market insiders suggest that a Kamala Harris win would be neutral for the economy, while Trump’s victory could positively impact India through domestic demand, lower commodity prices, supply chain shifts, and foreign policy changes.
Buy Dabur India, target price Rs 700: Motilal Oswal Financial Services (04-11-2024)
Motilal Oswal Financial Services has issued a buy call for Dabur India, setting a target price of Rs 700. Currently priced at Rs 541, Dabur has a strong presence in the FMCG sector. The company reported a net profit of Rs 417.28 crore for the recent quarter. The brokerage highlights Dabur’s broad distribution reach and potential for stock re-rating.
‘We have secured a place for large deals’ (04-11-2024)
‘Our growth in banking, financial services, and insurance (BFSI) is a prime example.’
Bajaj Auto records muted sales in October (04-11-2024)
Sells 4.79 lakh units
HCL Technologies opens new Singapore-based AI/Cloud Native Lab (04-11-2024)
The Lab, joining others in the US, UK, Germany and India, will be supported by EDB and assist enterprises in the region in accelerating their AI initiatives through HCLTech’s comprehensive suite of integrated AI and GenAI offerings, including AI Force and AI Foundry.
The Lab in Singapore will also partner with Nanyang Polytechnic and Singapore Polytechnic to collaborate on transferring knowledge and nurturing young talent and mid-career individuals In AI.
Hot stocks: Brokerage view on M&M, Nykaa and Sun Pharma (04-11-2024)
JPMorgan reports that Sun Pharma plans to appeal a judgment and may seek a settlement with Incyte to expedite its product launch. In a worst-case scenario, the launch could occur post-expiry in December 2026. The firm assigns an NPV of $546 million for Leqselvi, projecting 20% CAGR growth for the specialty business driven by existing products.